ArticleInfectious diseases and therapy2024

Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study.

Stefan Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.